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Background: Bri2 is a substrate for intramembrane proteolysis by SPPL2b.
Results: Reducing the -helical content of the Bri2 transmembrane domain increases its intramembrane cleavage by SPPL2b.
Destabilization of the Bri2 transmembrane domain is predominantly mediated by Gly-60.
Conclusion: A single helix-destabilizing glycine residue of the transmembrane domain of Bri2 is sufficient for efficient
intramembrane proteolysis by SPPL2b.
Significance: Understanding substrate requirements of intramembrane-cleaving proteases.
Regulated intramembrane proteolysis is a widely accepted
concept describing the processing of various transmembrane
proteins via ectodomain shedding followed by an intramem-
brane cleavage. The resulting cleavage products can be
involved in reverse signaling. Presenilins, which constitute
the active center of the -secretase complex, signal peptide
peptidase (SPP), and its homologues, the SPP-like (SPPL)
proteases aremembers of the family of intramembrane-cleav-
ing aspartyl proteases of the GXGD-type. We recently dem-
onstrated that Bri2 (itm2b) is a substrate for regulated
intramembrane proteolysis by SPPL2a and SPPL2b.
Intramembrane cleavage of Bri2 is triggered by an initial
shedding event catalyzed by A Disintegrin and Metallopro-
tease 10 (ADAM10). Additionally primary sequence determi-
nants within the intracellular domain, the transmembrane
domain and the luminal juxtamembrane domain are required
for efficient cleavage of Bri2 by SPPL2b. Using mutagenesis
and circular dichroism spectroscopy we now demonstrate
that a high -helical content of the Bri2 transmembrane
domain (TMD) reduces cleavage efficiency of Bri2 by
SPPL2b, while the presence of a GXXXG dimerization motif
influences the intramembrane cleavage only to a minor
extent. Surprisingly, only one of the four conserved
intramembrane glycine residues significantly affects the sec-
ondary structure of the Bri2 TMD and thereby its intramem-
brane cleavage. Other glycine residues do not influence the
-helical content of the transmembrane domain nor its
intramembrane processing.
Intramembrane-cleaving proteases (I-CLiPs)3 are involved
in a number of pivotal physiological and pathological processes,
such as malaria, Alzheimer disease, cholesterol metabolism,
Notch-signaling, removal of signal peptides, immune surveil-
lance, and processing of the hepatitis C viral core protein (1).
I-CLiPs trigger a variety of cellular pathways leading either to
degradation of transmembrane domains or to the liberation of
peptides, which in some cases are required for nuclear signaling
(2). In most, but not all cases, I-CLiPs are part of a two-step
proteolytic cascade known as regulated intramembrane prote-
olysis (RIP). The first step of RIP, commonly known as shed-
ding, removes a large part of the substrates’ ectodomain, which
is secreted. In a subsequent step the remaining membrane-
bound substrate is cleaved within its transmembrane domain
(TMD) to produce an intracellular domain (ICD) and low
molecular weight secreted peptides (2). Currently three classes
of I-CLiPs have been identified, the intramembrane metallo-
proteases, represented by the site-2-protease (S2P), intramem-
brane serine proteases, represented by the large family of rhom-
boid proteases and finally the GXGD aspartyl proteases (2–4).
The latter includes the presenilins (PS1 and PS2), which form
the catalytic subunit of the -secretase complex (5), signal pep-
tide peptidase (SPP) and its homologues, the SPP-like proteases
(SPPLs) (6, 7). They all share the conserved GXGD-motif in
TMD 7, which together with a YD-motif in TMD 6 and a PAL-
motif in TMD 9, forms the catalytic center of these proteases
(8–12). While -secretase exclusively accepts type-1-oriented
proteins as substrates, SPP and SPPLs only cleave type-2 trans-
membrane proteins (6, 7, 13).
Numerous substrates for almost all known I-CLiP classes
have now been described (1, 2). These I-CLiP substrates are
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-helical conformation to minimize the energetically unfavor-
able exposure of their amino acid side chains to the hydropho-
bic core of lipid bilayers (14). Because their peptide bonds are
hardly accessible to proteases, -helical TMDs are expected to
be poor protease substrates. To make TMDs susceptible to
intramembrane proteolysis their helical content may be
reduced by helix-destabilizing amino acids (15, 16). Amino
acids with potential helix destabilizing properties in TMDs are
in particular proline, glycine, asparagine, and serine (17). Con-
sistent with this hypothesis, the substrates of S2P, rhomboids,
and SPP have been shown to contain critical helix-destabilizing
moieties within their TMDs (18–21). However, for rhomboid
proteases it has been demonstrated recently, that additional
primary structure elements within the juxtamembrane domain
of the substrate determine the cleavage site, and are more
strictly required than TMD helix-destabilizing residues (22).
-Secretase substrates in contrast apparently do not contain
obvious primary sequence elements required for their recogni-
tion (13) and -secretase is therefore believed to be a rather
unselective “membrane proteasome” (23). However, for the
-amyloid precursor protein (APP), a major -secretase sub-
strate, it has been shown that the luminal juxtamembrane
domain (24) as well as a GXXXG dimerization motif within the
TMD (25) affect substrate recognition and cleavage by -secre-
tase (26). In line with these findings so far unknown determi-
nants within a short luminal juxtamembrane sequence of the
Bri2 protein as well as in the intracellular domain and the TMD
are required for efficient intramembrane proteolysis by signal
peptide peptidase-like 2b (SPPL2b) (27). To specify these deter-
minants in more detail, we now investigated whether helix
destabilizing amino acids in the TMD of Bri2 affect the effi-
ciency of intramembrane proteolysis. We demonstrate that a
single glycine residue in the N-terminal part of the Bri2 TMD
(G60) is essential for the destabilization of the -helical struc-
ture of the TMD and thus for its cleavage by SPPL2b. In con-
trast, the GXXXGmotif affects intramembrane cleavage of Bri2
only to aminor extent. Consistent with these findings, Gly-60 is
a major determinant of the secondary structure of the Bri2
TMD in lipid vesicles, while other potentially helix destabilizing
residues within the TMD of Bri2 do not influence secondary
structure and cleavage efficiency of Bri2.
EXPERIMENTAL PROCEDURES
Cell Culture, cDNAs, and Transfection—HEK293EBNA or
HEK293 TR cells (Invitrogen GmbH) were cultured in DMEM
with Glutamax (Invitrogen GmbH) supplemented with 10%
fetal calf serum (Invitrogen GmbH) and 1% penicillin/strepto-
mycin (Invitrogen GmbH) to the culture medium of HEK293
TR cells.
5 g/ml Blasticidin (Invitrogen GmbH) was added. The cell
lines expressing SPPL2b wt or the proteolytically inactive
SPPL2b D421A (28) containing a C-terminal hemagglutinin
(HA) tag (AYPYDVPDYA) as well as the Bri2E construct (27)
containing a N-terminal Flag tag (DYKDDDK) and a C-termi-
nal V5 tag (GKPIPNPLLGLDST) to enable the detection of the
Bri2 C-Peptide have been described before. Bri2 wt reflects
Bri2FC, which has been described before (27). Bri2 wt lacks
the propeptide and carries anN-terminal Flag tag (DYKDDDK)
and a C-terminal V5 tag (GKPIPNPLLGLDST) to detect Bri2
ICD species and the BRICHOS domain, respectively. The indi-
cated mutations have been introduced using site-directed
mutagenesis. Sequences of the respective oligonucleotides are
available upon request. All cDNA constructs were sequenced
for verification. Transient transfections of cellswere carried out
using Lipofectamine 2000 (Invitrogen GmbH) according to the
manufacturer’s instructions. To induce expression of the
SPPL2b constructs, cells were incubated with 1 g/ml doxycy-
cline (BD Biosciences, San Jose) added to the cell culture
medium for at least 48 h.
Antibodies, Immunoprecipitation, and Immunoblotting—
The anti-HA-peroxidase coupled 3F10 antibody was obtained
from Roche Diagnostics GmbH (Mannheim, Germany). The
monoclonal anti-FlagM2 and the polyclonal HA 6908 antibody
were obtained from Sigma, the poly- and monoclonal V5 anti-
bodies were purchased from Chemicon (Schwalbach, Ger-
many) and Invitrogen GmbH, respectively. Anti-mouse and
anti-rabbit secondary antibodies were purchased from Pro-
mega. Immunoprecipitation assays were carried out as
described previously (29). To detect Bri2 species in the cell
lysate or BRICHOS in the conditionedmedia sampleswere sep-
arated onTris-Tricine gels or 12% sodiumdodecyl sulfate-poly-
acrylamide gels, respectively. Proteinswere subsequently trans-
ferred to a polyvinylidene difluoride (PVDF) membrane
(Immobilon, Millipore Corporation, Eschborn, Germany) and
detected by using an enhanced chemiluminescence technique
(ECL)Western blottingDetectionReagent (GEHealthcare, Lit-
tle Chalfont, UK). For quantification, proteins were detected
using the enhanced chemiluminescence technique (ECL) Plus
Western blotting Detection System (GE Healthcare). The
chemiluminescence signals of at least six independent experi-
ments were measured with a CCD camera-based imaging sys-
tem (ImageQuant LAS-4000 Fuji Film). Intensities of individual
gels were normalized to one control experiment.Mean and S.D.
of all individual experiments were determined. The relative sig-
nal intensity of ICD compared with Bri2  Bri2 ICD of the
respective sample was measured for the constructs indicated
and set to 100% for Bri2 wt. Statistical significance was deter-
mined using Student’s t test. Statistical significant p values
0.05, 0.005, or 0.0005 are represented by *, ** or ***,
respectively.
Immunocytochemistry and Confocal Imaging—HEK293-
EBNA cells were grown on polylysine-coated glass coverslips to
50–80% confluence. After transient transfection with the indi-
cated Bri2 constructs, cells were fixed for 20 min with 3.7%
paraformaldehyde in phosphate-buffered saline (PBS), permea-
bilized for 20 min with 0.2% Triton X-100 in PBS (were indi-
cated) and blockedwith 1%bovine serumalbumin in PBS. Incu-
bations with the monoclonal V5 antibody were performed for
1 h at room temperature in PBS followed by incubation with
Alexa 488-coupled secondary antibodies (Molecular Probes).
Mounted samples were analyzedwith a Zeiss 510Meta confocal
laser scanning microscope system equipped with a 100/1.3
objective described previously (30).
Vesicle Preparation and CD Spectrometry—The synthetic
peptides covering the following sequences have been obtained
from Peptide Specialty Laboratories GmbH, Heidelberg.
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KYFALQPDD (MW 4432 Da); Bri2 G60A: VGQRRAWCW-
CMCFALAFMLAGVILGGAYLYKYFALQPDD (MW  4446
Da); Bri2 G71A: VGQRRAWCWCMCFGLAFMLAGVILAG-
AYLYKYFALQPDD (MW  4446 Da); Bri2 G72A: VGQRRA-
WCWCMCFGLAFMLAGVILGAAYLYKYFALQPDD (MW 
4446 Da); Bri2 GallA: VGQRRAWCWCMCFALAFMLAAVI-
LAAAYLYKYFALQPDD (MW  4488 Da).
0.3–0.4 mg of the respective peptide were mixed with
3.12 mg 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-choline
(POPC) in 1ml tert-butanol (Sigma). Themixturewas chilled in
liquid nitrogen and subsequently lyophilized. The phospholip-
id-peptide mixtures were hydrated in buffer (100 mM KCl, 20
mM sodium phosphate, pH 7.2) for 15 min at 30 °C resulting in
a final peptide concentration of80M. Small unilamellar ves-
icles (SUV) were prepared by sonication of the phospholipid-
peptide suspensions for 20 min under argon at temperatures
of 5 °C above the respective transition temperature tm of the
lipids. A Branson sonifier equipped with a microtip was
employed, using a duty cycle of 30%. CD spectraweremeasured
with a Jasco J-810 Spectropolarimeter (Jasco, Gross-Umstadt,
Germany) using a cuvette with a path length of 0.1 cm. Spectra
of 11 scans were averaged. CD data are expressed as the mean
residue ellipticity () in deg cm2 dmol1 at the respective wave
length in nm. The mean residue ellipticity was calculated from
themeasured ellipticity (, inmdeg) by dividing themolar ellip-
ticity (  100/([Protein]  d), d is the cuvette path length in
cm) by the amount of residues (n 39 for all Bri2 peptides). The
molecular weights of the peptides are indicated above.
RESULTS
Contribution of Glycine Residues within the TMD of BRi2 to
Its Intramembrane Cleavage—Bri2 (itm2b), the protein genet-
ically involved in familial British dementia (31) was recently
identified as a substrate for SPPL2b (27). After the release of a
4 kDa C-terminal propeptide (32, 33) Bri2 undergoes a shed-
ding event catalyzed by ADAM10, which removes the bulk of
the Bri2 ectodomain containing the BRICHOS domain (Refs.
27, 34 and Fig. 1A). The shedding event significantly facilitates
subsequent intramembrane cleavage by SPPL2b (35), which
generates a low molecular weight intracellular peptide (Bri2
ICD) and a secreted C-terminal peptide (Bri2 C-peptide; (Ref.
27 and Fig. 1A)). The efficiency of Bri2 intramembrane cleavage
depends on so far unknown determinants within the intracel-
lular domain, the TMD, and in the luminal juxtamembrane
domain of Bri2 (35). To further specify these determinants we
first investigated, whether mutation of potential helix-destabi-
lizing residueswithin theTMDofBri2 affect its intramembrane
cleavage by SPPL2b, as it has been suggested for S2P, rhomboid,
and SPP substrates (18–21). For this purpose a Bri2 variant
lacking all four glycine residues in its TMD (Bri2 GallA) was
generated (Fig. 1B). Because no other potential helix-destabi-
lizing residues are present in the Bri2 TMD, Bri2 GallA reflects
a mutant lacking all potential helix destabilizers. Compared
with wt Bri2 ICD production was strongly reduced when Bri2
GallA was co-expressed with SPPL2b (Fig. 1C). As expected
ICD production from both Bri2 variants was fully blocked in
cells expressing the catalytically inactive SPPL2b D421A (Fig.
1C). Quantification of ICD production relative to total Bri2
revealed a significant reduction to 42.4%	 17.3% inBri2GallA-
expressing cells (Fig. 1D). To ensure that the reduced ICD level
is neither due to an enhanced proteosomal degradation nor to
missorting of the Bri2 GallA substrate we treated cells co-ex-
pressing SPPL2b and either Bri2 wt or Bri2 GallA with 10 M
MG132 (Fig. 1E) and determined the subcellular localization of
Bri2 by immunofluorescence (Fig. 1G), respectively. Inhibition
of proteosomal degradation stabilized all Bri2 species, includ-
ing Bri2 ICDs to a similar extent regardless whether Bri2 wt or
Bri2 GallA was expressed (Fig. 1E). Moreover, ICD levels gen-
erated from Bri2 GallA in cells treated with MG132 were
reduced to a similar extent as in nontreated cells (42.9% 	
16.3%; Fig. 1F). Cell surface transport of the Bri2 protein was
not affected by the removal of glycine residues from theTMDas
shown by immunofluorescence staining of nonpermeabilized
cells (Fig. 1G). These findings therefore demonstrate that
removal of all potential helix destabilizing residues from the
TMD of Bri2 significantly reduces its intramembrane cleavage
by SPPL2b.
The GXXXG Dimerization Motif Is Not the Major Determi-
nant for the Intramembrane Cleavage of Bri2—Because the
removal of all glycine residues also disrupts the GXXXG
dimerization motif in the TMD of Bri2, we next investigated
whether a single point mutation in the GXXXGmotif would be
sufficient to copy the effect of the Bri2 GallAmutation on Bri2
ICD production. An alanine mutation of the first glycine resi-
due in the GXXXG motif (G67A) did not significantly affect
generation of the Bri2 ICD (92.1	 23.4%; p 0.54; Fig. 2,A and
B), suggesting that the effect on intramembrane proteolysis
observed in the Bri2GallAmutation (Fig. 1) is not caused by the
potential disruption of the GXXXGmotif.
Because it has been shown that glycine to isoleucine muta-
tions in the GXXXGmotif of APP affect its cleavage by -secre-
tase to a much greater extent than glycine to alanine mutations
(26), we also introduced a G67I mutation to further investigate
whether the GXXXG motif has an essential role in the
intramembrane proteolysis of Bri2 by SPPL2b. Although the
G67I mutation reduced Bri2 ICD generation, (71.8 	 14.9%
(p 0.0003); Fig. 2,C andD) the reductionwas significantly less
as compared with the Bri2 GallA mutation (42.4 	 17.3% (p 
0.000004); Fig. 1D). Mutation of Gly-67 did not affect cell sur-
face transport of the Bri2 protein as shown by immunofluores-
cence staining of nonpermeabilized cells (Fig. 2E).
Gly-60 in theN-terminal Part of the Bri2 TMD Is Required for
Efficient Cleavage by SPPL2b—To test whether the interplay of
all glycine residues in the TMD of Bri2 is necessary for efficient
intramembrane proteolysis or whether a single glycine residue
is sufficient to allow efficient cleavage by SPPL2b, we generated
individual glycine mutations. Interestingly, mutagenesis of
Gly-60was sufficient to reduce Bri2 ICD generation to a similar
extent (50.6	 13.8%; p 41013) as mutagenesis of all glycine
residues (GallA; 42.4 	 17.3%; p  0.000004). In contrast
SPPL2b-dependent ICD generation was hardly changed for
Bri2 G71A (87.6 	 20.0%; p  0.15) and for Bri2 G72A (87.3 	
16.5%; p  0.03) (Fig. 3, A and B). Cell surface transport of the
Bri2 proteinwas not affected by any of the pointmutations (Fig.
3C). To further ensure that the G60Amutation in Bri2 directly
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affects intramembrane cleavage and not shedding, we co-ex-
pressed SPPL2b and Bri2E cDNA constructs, which lack the
entire Bri2 ectodomain and have been previously shown to be
solely processed by SPPL2a and SPPL2b independent of a pre-
ceding shedding event (27). Because of a V5-tag added to the
C terminus, these constructs furthermore allowed us to detect
the C-terminal counterpart (Bri2 C-Peptide) of the Bri2 ICD in
the conditionedmedia (27). In line with the data obtained upon
expression of the Bri2 constructs ICD generation in cells co-ex-
pressing SPPL2b and either Bri2E G60A (53.5 	 16.6%; p 
1  1010) or Bri2E GallA (48.2 	 15.3%; p  8  109) was
significantly reduced, while SPPL2b-dependent ICD genera-
tion was hardly changed for Bri2E G71A (106.3 	 7.1%; p 
0.04), Bri2 E G72A (109.7 	 19.6%; p  0.14) and Bri2 E
G67A (105.9 	 11.2%; p  0.10) (Fig. 4, A and B). Consistent
with these findings levels of Bri2 C-peptides in conditioned
media from cells expressing Bri2E G67A, Bri2E G71A, or
Bri2E G72A were hardly changed compared with Bri2E wt,
while those of Bri2EG60A and Bri2EGallA-expressing cells
were markedly reduced (Fig. 4A). Thus, these findings inde-
pendently confirm the conclusions drawn from the expression
of the full-length constructs and demonstrate thatG60 strongly
affects Bri2 cleavage by SPPL2b. As demonstrated for the Bri2
variants, all Bri2 E variants localized to the cell surface (Fig.
4C).
Gly-60 Selectively Disrupts the -Helical Structure of the Bri2
TMD—Because TMDs tend to adopt an -helical conforma-
tion in the hydrophobic core of lipid bilayers (14), it was pro-
FIGURE 1. Glycine residues within the TMD of BRi2 greatly facilitate its intramembrane cleavage by SPPL2b. A, model depicting the proteolytic proc-
essing of Bri2 by furin, shedding, and subsequent intramembrane proteolysis. B, amino acid sequence of the Bri2 TMD and the flanking regions. The potential
helix-destabilizing residues are enlarged and the corresponding alanine mutations are indicated below. C, Bri2 GallA is less efficiently processed by SPPL2b
than Bri2 wt. Co-expression of Bri2 wt or Bri2 GallA with SPPL2b wt or the catalytically inactive SPPL2b D421A mutant shows reduced ICD generation for Bri2
GallA. Bri2 and Bri2 ICD were detected using the anti-FLAG antibody. The corresponding BRICHOS domain was isolated from conditioned media using the
polyclonal V5 antibody. D, quantitative analysis of the experiment shown in C. Data represent the means 	 S.D. of twelve independent experiments. SPPL2b-
dependent ICD generation is significantly reduced to 42.4 	 17.3% for Bri2 GallA (p  0.000004). E, proteasomal degradation of Bri2 GallA is not increased. Cells
co-expressing SPPL2b wt and either Bri2 wt or Bri2 GallA were treated with 10 M MG132 or the respective carrier for 24h. Bri2 and Bri2 ICD were detected using
the anti-FLAG antibody. The corresponding BRICHOS domain was isolated from conditioned media using the polyclonal V5 antibody. F, quantitative analysis
of the experiment shown in E. Data represent the means 	 S.D. of six independent experiments. G, cellular localization of Bri2 GallA is similar to Bri2 wt.
Immunohistochemistry of HEK293 TR cells transfected with Bri2 wt or Bri2 GallA reveals similar localization of both proteins at the plasma membrane (staining
without Triton X-100) and within the secretory pathway (staining with Triton X-100). Bri2 wt and Bri2 GallA were detected using an anti-V5 antibody. Scale bar,
10 M.
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posed that helix-destabilizing residues are required to facilitate
intramembrane proteolysis (19, 20). We therefore asked
whether the glycine residues in the TMD of Bri2 affect its sec-
ondary structure. To address this question, synthetic peptides
reflecting the Bri2 TMD and the flanking regions (Fig. 1B) were
generated. The lyophilized peptideswere reconstituted in small
unilamellar vesicles (SUVs) consisting of 1-palmitoyl-2-oleoyl-
sn-glycero-3-phospho-choline (POPC), and circular dichrosim
(CD) spectra were collected. As indicated by the single mini-
mum of the ellipticity between 220 and 230 nm, the peptide
reflecting the Bri2 wt TMD is mainly in a -strand like confor-
mation (Fig. 5). In contrast, the peptides mimicking the G60A
or the Bri2 GallA mutation revealed spectra with a smaller
ellipticity at 210 nm to 215 nm. In particular the Bri2 GallA
peptide revealed a minimum of the ellipticity at 210 nm, sug-
gesting a predominantly -helical conformation (Fig. 5). In
contrast, peptides carrying the G71A or the G72A mutation
behaved highly similar to that of the Bri2 wt peptide. The sec-
ondary structure of a peptide carrying the G67A mutation,
which is according to the biochemical data described above
presumably in a similar conformation as the wt peptide, could
not be determined, because the synthesis of the peptide was
impossible. These data indicate that the non -helical confor-
mation of the Bri2 TMD is mainly caused by Gly-60 in the
N-terminal part of theTMD,while potential helix-destabilizing
residues in theC-terminal part of theTMDdonot influence the
secondary structure of the Bri2 TMD in lipid vesicles. Thus the
biophysical in vitro data are in line with our findings in living
cells.
DISCUSSION
Over the past years, intramembrane proteases have attracted
a lot of attention, because their substrates are involved in a
variety of diseases such as Alzheimer disease, Morbus Chron,
psoriasis, hepatitis C, and malaria (4). In contrast to commonly
known proteases, intramembrane proteases are capable of
cleaving their substratewithin the hydrophobic environment of
a lipid bilayer (36), which raises the question of how substrate
recognition and cleavage under these exceptional conditions is
mediated. For the vast majority of classical proteases, which
cleave their substrates in a hydrophilic environment, it has been
shown that they almost exclusively process substrates, which
present themselves in an extended -strand conformation,
while -helically folded regions of proteins are highly resistant
to proteolysis (16). The results of our study indicate that the
intramembrane cleavage of Bri2 by SPPL2b, a member of the
GXGD-type intramembrane aspartyl proteases, is also only effi-
ciently catalyzed if the TMDof Bri2 adopts a-strand-like con-
formation, while TMDs adopting a predominantly -helical
conformation are poor substrates. Similar data have been
FIGURE 2. The GXXXG dimerization motif is not a major determinant for the intramembrane cleavage of Bri2. A, GXXXG to AXXXG mutation does not
change Bri2 ICD generation. Co-expression of Bri2 wt or Bri2 G67A with SPPL2b wt or the inactive SPPL2b D421A revealed similar ICD production from both Bri2
variants. All proteolytic products were detected as described in Fig. 1C. B, quantitative analysis of the experiment shown in A. Data represent the means 	 S.D.
of eight independent experiments. C, GXXXG to IXXXG mutation slightly reduced SPPL2b dependent Bri2 ICD generation. Co-expression of Bri2 wt or Bri2 G67I
with SPPL2b wt or the inactive SPPL2b D421A revealed a slightly reduced ICD production from Bri2 G67I. All proteolytic products were detected as described
in Fig. 1C. D, quantitative analysis of the experiment shown in C. Data represent the means 	 S.D. of eighteen independent experiments. E, mutations in GXXXG
motif did not affect subcellular localization of Bri2. Immunohistochemistry of HEK293 TR cells transfected with Bri2 wt, Bri2 G67A, or Bri2 G67I reveals similar
localization of all Bri2 protein variants at the plasma membrane (staining without Triton X-100) and within the secretory pathway (staining with Triton X-100).
Scale bar, 10 M.
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FIGURE 4. Gly-60 directly affects the intramembrane cleavage of Bri2 by SPPL2b and not shedding of Bri2. A, Bri2 E variants lacking the BRICHOS
domain affect Bri2 ICD production similar to the respective full-length constructs. Co-expression of SPPL2b wt and the indicated Bri2E mutants
revealed a significantly reduced Bri2 ICD generation only in cells expressing Bri2E G60A or Bri2E GallA. Bri E and its corresponding ICDs were
detected using the anti-FLAG antibody. The corresponding Bri2 C-peptides were isolated from conditioned media after 4 h using the polyclonal V5
antibody. B, quantification of the experiment shown in A. Data represent the means 	 S.D. of at least twelve independent experiments. C, Bri2 E
variants all share a similar subcellular localization. Immunohistochemistry of HEK293 TR cells transfected with the indicated Bri2 E variants reveals
similar localization of all protein variants at the plasma membrane (staining without Triton X-100 and within the secretory pathway (staining with Triton
X-100). Scale bar, 10 M.
FIGURE 3. Gly-60 in the N-terminal part of the Bri2 TMD enables efficient cleavage by SPPL2b. A, G60A mutation in the TMD of Bri2 strongly reduces
intramembrane cleavage. Co-expression of SPPL2b wt and the indicated Bri2 mutants revealed a strongly reduced Bri2 ICD generation only in cells expressing
the G60A or the GallA mutant. All proteolytic products were detected as described in Fig. 1C. B, quantification of the experiment shown in A. Data represent the
means 	 S.D. of at least twelve independent experiments. C, glycine mutations in the Bri2 TMD do not affect subcellular localization of Bri2. Immunohisto-
chemistry of HEK293 TR cells transfected with the indicated Bri2 variants reveals similar localization of all protein variants at the plasma membrane (staining
without Triton X-100) and within the secretory pathway (staining with Triton X-100). Scale bar, 10 M.
Substrate Determinants for Intramembrane Cleavage by SPPL2b
FEBRUARY 10, 2012 • VOLUME 287 • NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 5161










obtained for SPPL2a, a close homologue of SPPL2b (data not
shown).
Our findings are consistent with studies on other intramem-
brane proteases such as S2P (18), SPP (20), and rhomboids (19,
21), which all suggest that the respective substrates of these
intramembrane proteases are only efficiently processed if
potentially helix-destabilizing residues are present in their
TMDs. Helix-destabilizing residues like proline, glycine, aspar-
agines, and serine have been suggested to disrupt the -helical
conformation which TMDs tend to adopt in the hydrophobic
environment of cellular membranes (17) and therefore facili-
tate their cleavage by intramembrane proteases.
Using CD spectroscopy, we demonstrate that Gly-60 in the
TMD of Bri2 is by itself able to stabilize the Bri2 TMD in a
-strand-like conformation when incorporated in lipid vesi-
cles. Unexpectedly, two other glycine residues in the C-termi-
nal part of the Bri2 TMD did not affect the secondary structure
of the Bri2 wt TMD, demonstrating that potential helix-desta-
bilizing residues in the context of a TMD may not generally
disturb its favored -helical conformation.
Recently, a study on rhomboids, a family of intramembrane
serine proteases, demonstrated that a specific recognitionmotif
surrounding the cleavage site is more strictly required for effi-
cient substrate turnover than helical instability of the substrate
TMD (22). However, the same study suggests that rhomboid
substrates with their recognition motif located within or near
their TMD require the presence of helix-destabilizing residues
in the TMD to be efficiently cleaved (22). Assuming that sub-
strate recognition and cleavage by rhomboid proteases would
be governed by a similar mechanism as by GXGD intramem-
brane aspartyl proteases, one would expect an additional rec-
ognitionmotif close to eithermembrane border or in one of the
juxtamembrane domains of Bri2. Although as yet no consistent
recognition motif has been identified in the known SPPL2b
substrates, our data do not exclude the existence of such a
motif. In particular because swapping experiments using the
juxtamembrane domains of Bri3, a close homologue of Bri2 but
not a substrate for SPPL2b, have demonstrated that both jux-
tamembrane domains of Bri2 contain as yet unknown determi-
nants that trigger intramembrane cleavage by SPPL2b (35).
However, whether these determinants are specific sequence
motifs or rather secondary structure requirements remains to
be elucidated.
In line with this, presenilin, another member of the GXGD
intramembrane aspartyl protease family, also requires so far
incompletely characterized determinants in the TMD, the
cytosolic domain (13), and the luminal juxtamembrane domain
(24) of its substrates.
In addition it has been shown that dimerization of APP via a
GXXXG dimerization motif in its TMD strongly reduces its
intramembrane cleavage by -secretase (37). APP is a well-
characterized -secretase substrate responsible for the genera-
tion of amyloid- (A), which forms pathologic aggregates in
the brains of AD patients (38). Whether dimerization of APP
reduces the total amount of secreted A (37) or specifically
reduces the pathogenic A42 by modulating cleavage specific-
ity (26, 39) is controversially discussed. Although in contrast to
APP (25), it has not yet been formally proven that the GXXXG
motif in the Bri2 TMD indeed is capable of triggering Bri2
dimerization, our present data suggest that a potential
dimerization of Bri2 via a GXXXG in the TMD affects its
intramembrane cleavage by SPPL2b only to a minor extent
compared with the robust effect that was observed for APP (26,
37, 39).
The Bri2 TMD, including Gly-60 and the GXXXG motif, is
highly conserved among species. In addition Gly-60 of Bri2 is
also conserved in the TMD of human Bri3, which is a very poor
substrate for SPPL2b (35). These observations may indicate
that Gly-60 is only able to successfully destabilize an -helix of
a TMD if embedded in a certain context. However, because we
failed to synthesize the peptide reflecting the Bri3 TMD, we
could not finally prove this hypothesis in this study.
Taken together, our data suggest that the Bri2 TMD domain
is only efficiently cleaved by SPPL2b if it adopts a non -helical
structure. Gly-60 has a high impact in destabilizing the -heli-
cal character of the Bri2 TMD. Whether the secondary struc-
ture of the TMD is solely determined by Gly-60 or may addi-
tionally be affected by other primary structure elements and
whether the lipid composition of certain cellular membranes
may affect the secondary structure of the Bri2 TMD remains,
however, to be elucidated.
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